Merck & Co., Inc. - Company & Market Research Reports

Home /
Companies /
Merck & Co., Inc.

Merck & Co., Inc. is a global healthcare company with operations in more than 140 countries. It offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus and other diseases. The company has collaboration agreements with Adaptimmune Therapeutics plc and Agenus; and a research agreement with Proteros Biostructures. Founded in 1891, it is headquartered in Kenilworth, New Jersey.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 332
Infectious Diseases Drugs 243
Vaccines 240
Animal Healthcare/Veterinary 191
Endocrine and Metabolic Disorders Drugs 174
Immune Disorders Drugs 154
Women's Health 134
Animal Pharmaceuticals 132
Central Nervous System Drugs 132
Cardiovascular Drugs 124
Pharmaceuticals 112
Musculoskeletal Disorders Drugs 102
Drug Discovery 97
Biopharmaceuticals 92
Respiratory Drugs 81
Oncology 74
Allergy and Immunology 72
Clinical Trials 72
Sexual and Reproductive Health Drugs 71
Liver and Kidney Disorders Drugs 69
Diabetes Drugs 67
Antibiotics 61
Biotechnology 60
Drug Delivery 60
Gastrointestinal Drugs 60
Enzymes 57
Genomics 49
Analgesics 43
Optical Disorders Drugs 42
Dermatological Drugs 42
Brain Cancer Drugs 41
Skin Cancer Drugs 39
Infusions and Injectables 37
Diagnostics 36
Pulmonary Medicine 35
Lymphoma Drugs 35
Cancer Vaccines 33
Hematological Drugs 32
Biosimilars and Biosuperiors 32
Pharmaceutical Intermediates 31
Lung Cancer Drugs 29
Urological Disorders Drugs 29
Optical 28
Pharmaceutical Manufacturing 28
HIV/AIDS Drugs 27
Liver Cancer Drugs 26
Over the Counter (OTC) Drugs 25
Healthcare Services 24
Immunosuppressive Drugs 24
Neurology 23
Prostate Cancer Drugs 23
Infectious Disease Testing 23
Cervical Cancer Drugs 22
Allergy Drugs 22
Breast Cancer Drugs 21
Cardiology 21
Leukemia Drugs 20
Mental Disorders Drugs 19
Psoriasis Drugs 19
Asthma Drugs 18
Colon Cancer Drugs 17
Drugs by Therapeutic Area 16
Inhalers and Nebulisers 16
Dermatology 16
Vitamins and Dietary Supplements 16
Bladder Cancer Drugs 15
Biomarkers 15
E-Healthcare 14
Medical Devices 14
Hematology 14
Fertility Services 13
Ovarian Cancer Drugs 13
Pancreatic Cancer Drugs 13
Pediatrics 13
Gastroenterology 13
Alzheimer's Disease Drugs 13
Urology and Nephrology 12
Nanomedicine 12
Therapeutic Area 11
Generic Drugs 11
Kidney Cancer Drugs 11
Anti-Obesity Drugs 11
Transdermal and Transmucosal Drug Delivery 10
Respiratory Devices 10
Thyroid Cancer Drugs 10
In Vitro Diagnostics 9
Anesthetic Drugs 8
Mental Health 8
Bronchitis Drugs 7
Healthcare 6
Needles and Syringes 6
Uterine Cancer Drugs 6
Other Healthcare Facilities 6
Laboratory Equipment 6
Endocrinology 6
Company Reports 5
Proteomics 5
Hepatology 4
Cough and Cold Drugs 4
Surgical Procedures 4
Cardiovascular Devices 3
Diabetes Devices 3
Hospital Management 3
Molecular Diagnostics 3
Palliative Care 3
Acne Drugs 3
Anxiety Drugs 3
Schizophrenia Drugs 3
Addiction Disorders Drugs 2
Patient Monitoring Equipment 2
Pharmacoeconomics 2
Laboratory Testing 2
Dental 2
Mammography 2
Stem Cells 2
Blood Banking 2
Biomaterials 2
ENT Devices 2
Nursing 2
Surgical Devices 2
Endoscopy 2
Clinical Skills 2
Maternal and Neonatal Care 2
Orthopedic Devices 1
Dialysis 1
Cholesterol Testing 1
Managed Care 1
Wound Care 1
Neurology Devices 1
Contrast Media 1
Nuclear Medicine and Radiopharmacology 1
Anatomy 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

3,360 Results (Page 97 of 168)
- Relevance
  Sort by

The Corporate Reputation of Pharma in 2021- The Patient Perspective - Germany Edition - The Views of 151 German Patient Groups

 Report
August 2022
59 Pages
Germany

€9510EUR$11,039USD£8,000GBP

Retinoblastoma Treatment Market

 Report
January 2024
200 Pages
Global

From

€3700EUR$4,150USD£3,222GBP

Nasopharyngeal Cancer Market Analysis & Forecast to 2024-2034

 Report
January 2024
200 Pages
Global

From

€3700EUR$4,150USD£3,222GBP

Veterinary Vaccines Market Report and Forecast 2023-2031

 Report
May 2023
147 Pages
Global

From

€4412EUR$4,949USD£3,842GBP

Influenza Vaccine Market Report and Forecast 2023-2031

 Report
May 2023
147 Pages
Global

From

€4412EUR$4,949USD£3,842GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Adenoid Cystic Carcinoma- Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1114EUR$1,250USD£970GBP

Glioblastoma Multiforme (GBM) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
1036 Pages
Global

From

€2229EUR$2,500USD£1,941GBP

Fallopian Tube Cancer Therapeutics Market 2025-2029

 Report
August 2025
224 Pages
Global

From

€2229EUR$2,500USD£1,941GBP

Inhibitor Of Apoptosis (IAP) Antagonist- Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1114EUR$1,250USD£970GBP

Eg5 Inhibitor - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1114EUR$1,250USD£970GBP

Beta-3 Receptors Agonist - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1114EUR$1,250USD£970GBP

Recombinant Vaccines Market Report and Forecast 2023-2031

 Report
April 2023
147 Pages
Global

From

€4412EUR$4,949USD£3,842GBP

Belgium Pharmaceutical Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022-2027)

 Report
July 2022
85 Pages
Belgium

From

€4235EUR$4,750USD£3,687GBP

Conjugate Vaccine Market Report and Forecast 2023-2031

 Report
April 2023
147 Pages
Global

From

€4412EUR$4,949USD£3,842GBP

Cholera Vaccines Market Report and Forecast 2023-2031

 Report
April 2023
147 Pages
Global

From

€4412EUR$4,949USD£3,842GBP

Pulmonary Arterial Hypertension Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030

 Report
October 2023
146 Pages
Global

From

€3700EUR$4,150USD£3,222GBP

Glioblastoma Treatment Drugs Market - Global Strategic Business Report

 Report
March 2026
287 Pages
Global

From

€5216EUR$5,850USD£4,541GBP

Brain Tumor Diagnosis and Treatment - Global Strategic Business Report

 Report
March 2026
173 Pages
Global

From

€5216EUR$5,850USD£4,541GBP

Brain Tumor Therapeutics - Global Strategic Business Report

 Report
March 2026
182 Pages
Global

From

€4413EUR$4,950USD£3,843GBP

Malignant Glioma Therapeutics - Global Strategic Business Report

 Report
March 2026
383 Pages
Global

From

€5216EUR$5,850USD£4,541GBP

3,360 Results (Page 97 of 168)
- 1
- 95
- 96
- 97
- 98
- 99

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.